Apelin-36 vs Vasostatin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Apelin-36 is the full-length 36-amino acid form of the apelin peptide family, encoded by the APLN gene. It activates the APJ (APLNR) receptor, a Gi-coupled GPCR, producing cardiovascular effects including vasodilation, positive inotropy, and cardioprotection. The largest naturall...
Calculate Apelin-36 dose →Vasostatin refers to the N-terminal fragments of chromogranin A (CgA), particularly CgA1-76 (Vasostatin-1) and CgA1-113 (Vasostatin-2), generated by proteolytic processing of the chromogranin A precursor. While catestatin (CgA352-372) is the C-terminal CgA fragment with anti-cate...
Calculate Vasostatin dose →| Parameter | Apelin-36 | Vasostatin |
|---|---|---|
| Category | Cardiovascular Peptide | Cardiovascular Peptide |
| Research | Preclinical / Phase 2 | Preclinical Research |
| Half-Life | 2-5 minutes (IV) | ~20-30 minutes (estimated) |
| Typical Dose | 1-10 nmol/kg IV (research) | 0.1-10 nmol/kg IV (animal) |
| Frequency | Variable | Acute dosing |
| Route | IV / SC (research) | IV (research) |
| FDA Status | Not approved | Research compound |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.